Study of TEV-50717 in Relieving Tics Associated With Tourette Syndrome
Study Title
- A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS)
Teva Identifier
- TV50717-CNS-30060 | 2017-002976-24
ClinicalTrials.gov Identifier
- NCT03571256
Study Status
- Completed
Trial Condition(s)
- Tourette Syndrome
Interventions
- Drug: TEV-50717 | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 6 Years to 16 Years
Trial Duration
- May 31, 2018 - December 9, 2019
Phase
- Phase 3
Additional info
Study Type
Interventional
